Delving into the Latest Updates on Wharton jelly derived mesenchymal stem cell exosomes(Tc Erciyes University) with Synapse

Overview

Basic Info

Drug Type

Exosomes, Mesenchymal stem cell therapy

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Congenital DisordersEye DiseasesOther Diseases

Active Indication

Retinitis Pigmentosa

Inactive Indication-

Originator Organization

Tc Erciyes University

Active Organization

Tc Erciyes University

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2/3

First Approval Date-

Regulation-

Login to view timeline

This clinical trial aims to study the efficacy of umbilical cord-derived mesenchymal stem cells and their exosomes in the treatment of retinitis pigmentosa. The participants will be randomized into 3 groups. Functional and structural parameters will be compared before and after the injections and also will be compared among the groups to reveal whether stem cell and their exosomes are more effective than placebo.

Start Date05 Aug 2022

Sponsor / Collaborator

Tc Erciyes University

100 Clinical Results associated with Wharton jelly derived mesenchymal stem cell exosomes(Tc Erciyes University)

Login to view more data

100 Translational Medicine associated with Wharton jelly derived mesenchymal stem cell exosomes(Tc Erciyes University)

Login to view more data

100 Patents (Medical) associated with Wharton jelly derived mesenchymal stem cell exosomes(Tc Erciyes University)

Login to view more data

100 Deals associated with Wharton jelly derived mesenchymal stem cell exosomes(Tc Erciyes University)

Login to view more data